Miguel Pupiales, MD
Pain Medicine · Albuquerque, NMNPI 1306876966
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.7% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Scilex Pharmaceuticals Inc. at 46.5% of the total. Reporting peaked in 2020 at $620 and has fallen 87.9% since, to $75 in 2024. That places this record below the midpoint for pain medicine clinicians in NM, where the typical reported total is $2,719.
Across 77 payments — averaging $21.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scilex Pharmaceuticals Inc.$777
- Electronic Waveform Lab, Inc.$525
- Tactile Systems Technology Inc$161
- Pfizer$97
- Daiichi Sankyo Inc.$64
- Biodelivery Sciences International, Inc.$28
- plus $19 from 1 others
What the payments were for
- Food & beverage$1,58395%
- Education$885%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scilex Pharmaceuticals Inc. | 35 | $777 |
| Electronic Waveform Lab, Inc. | 23 | $525 |
| Tactile Systems Technology Inc | 7 | $161 |
| Pfizer | 5 | $97 |
| Daiichi Sankyo Inc. | 4 | $64 |
| Biodelivery Sciences International, Inc. | 2 | $28 |
| AbbVie | 1 | $19 |
How this compares
$1,671 in reported general payments places this provider in the 35th percentile of 36 pain medicine providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZonegranZonisamide | 12 | $36,998 |
| OxycontinOxycodone Hcl | 38 | $12,424 |
| Hysingla ErHydrocodone Bitartrate | 11 | $7,088 |
| Oxycodone Hcl | 215 | $5,477 |
| Tramadol Hcl ErTramadol Hcl | 21 | $3,679 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 93 | $2,060 |
| Doxycycline Hyclate | 81 | $1,775 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 84 | $1,738 |
| Doxepin Hcl | 66 | $1,266 |
| Hydromorphone ErHydromorphone Hcl | 12 | $1,230 |
| Tramadol Hcl | 34 | $1,190 |
| Gabapentin | 84 | $989 |
| Omega-3 Acid Ethyl Esters | 17 | $978 |
| Celecoxib | 32 | $927 |
| Hydromorphone Hcl | 36 | $779 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Albuquerque
- John WatkinsAlbuquerque$22K
- Craig RumbaughAlbuquerque$11K
- Eugene KoshkinAlbuquerque$10K
- Matthew BergstenAlbuquerque$7K
- Lauren HarrisAlbuquerque$6K
- Melissa MerhegeAlbuquerque$5K
- Jeremy ChastainAlbuquerque$5K
- Joshu RaitenAlbuquerque$4K
- Thomas WhalenAlbuquerque$4K
- Matthew ValerianoAlbuquerque$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.